| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.44 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |